CTi Biopharma Corp Probability of Future Stock Price Finishing Under 9.1
| CTICDelisted Stock | USD 9.09 0.00 0.00% |
CTi |
CTi Biopharma Target Price Odds to finish below 9.1
The tendency of CTi Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 9.10 after 90 days |
| 9.09 | 90 days | 9.10 | about 85.35 |
Based on a normal probability distribution, the odds of CTi Biopharma to stay under $ 9.10 after 90 days from now is about 85.35 (This CTi Biopharma Corp probability density function shows the probability of CTi Stock to fall within a particular range of prices over 90 days) . Probability of CTi Biopharma Corp price to stay between its current price of $ 9.09 and $ 9.10 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 7.75 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, CTi Biopharma will likely underperform. Moreover CTi Biopharma Corp has an alpha of 1.344, implying that it can generate a 1.34 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CTi Biopharma Price Density |
| Price |
Predictive Modules for CTi Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CTi Biopharma Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CTi Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CTi Biopharma is not an exception. The market had few large corrections towards the CTi Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CTi Biopharma Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CTi Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.34 | |
β | Beta against Dow Jones | 7.75 | |
σ | Overall volatility | 2.24 | |
Ir | Information ratio | 0.14 |
CTi Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CTi Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CTi Biopharma Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CTi Biopharma Corp is not yet fully synchronised with the market data | |
| CTi Biopharma Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 53.95 M. Net Loss for the year was (92.99 M) with profit before overhead, payroll, taxes, and interest of 50.43 M. | |
| CTi Biopharma Corp currently holds about 81.64 M in cash with (81.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
CTi Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CTi Stock often depends not only on the future outlook of the current and potential CTi Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CTi Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 114.7 M | |
| Cash And Short Term Investments | 79.9 M |
CTi Biopharma Technical Analysis
CTi Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. CTi Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CTi Biopharma Corp. In general, you should focus on analyzing CTi Stock price patterns and their correlations with different microeconomic environments and drivers.
CTi Biopharma Predictive Forecast Models
CTi Biopharma's time-series forecasting models is one of many CTi Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CTi Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CTi Biopharma Corp
Checking the ongoing alerts about CTi Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CTi Biopharma Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CTi Biopharma Corp is not yet fully synchronised with the market data | |
| CTi Biopharma Corp has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 53.95 M. Net Loss for the year was (92.99 M) with profit before overhead, payroll, taxes, and interest of 50.43 M. | |
| CTi Biopharma Corp currently holds about 81.64 M in cash with (81.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |